Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Research deep dives

When it's not MS

Last reviewed November 16, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.

MS is diagnosed by pattern, and other conditions can produce the same pattern. Studies that re-examine people carrying an MS diagnosis find a meaningful proportion who have something else.

This is not a reason for doubt about a well-established diagnosis. It is a reason the exclusion step exists, and a reason an atypical picture deserves a second look.

Related pages: Multiple sclerosis (MS)

The bottom line

What we know
  • Several conditions mimic MS clinically and radiologically.
  • NMOSD and MOGAD are distinct antibody-mediated diseases with different treatment.
  • Some MS drugs make NMOSD worse.
  • White matter changes on MRI are common and not specific to MS.
What is still open
  • How often MS is misdiagnosed, with published estimates varying widely.
  • How to interpret MS-like lesions in older adults, where other causes are common.

The story, step by step

  1. 1. NMOSD ()
  2. 2. MOGAD ()
  3. 3. B12 and other treatable causes ()
  4. 4. Inflammatory and vascular ()
  5. 5. Asking the question ()
What the evidence labels mean
GuidelineAn official recommendation from an expert group after weighing all the evidence.
Review of many studiesCombines the results of many studies (a systematic review or meta-analysis).
Randomized trialPeople were randomly given a treatment or a comparison, the best way to test cause and effect.
Large observational studyFollows many people over time. Shows strong links, but not always cause and effect.
Small or early studyA small study, case series, or first results. Needs to be confirmed.
Lab or animal studyDone in cells or animals. May not apply to people.
Part 1 of 5

The one that must not be missed

Review of many studies

What happens

Neuromyelitis optica spectrum disorder looks like MS and is treated differently.

What the research shows

  • It causes severe optic neuritis, often in both eyes or with poor recovery, and long spinal cord lesions spanning three or more vertebral segments, which MS rarely does.
  • A characteristic feature is intractable hiccups, nausea or vomiting lasting days, from a lesion in a specific part of the brainstem.
  • Most cases are identified by an antibody against aquaporin-4, a water channel on support cells in the brain. The blood test is now routine where the picture is atypical.
  • Attacks cause more damage than MS relapses do, so prevention matters more, and effective targeted treatments now exist.
  • Several MS drugs, including interferon beta, natalizumab and the S1P modulators, can make NMOSD worse. This is the single clearest reason the distinction is made before treatment starts.

Why it matters

Severe optic neuritis, a long spinal cord lesion, or persistent unexplained hiccups and vomiting should prompt antibody testing.

What's still uncertain

  • Some people have the clinical syndrome without detectable antibodies.

Read more

Next: MOGAD

Part 2 of 5

A separate antibody disease

Review of many studies

What happens

MOG antibody-associated disease, recognized as distinct relatively recently.

What the research shows

  • Caused by antibodies against myelin oligodendrocyte glycoprotein, a protein on the outer surface of myelin.
  • It commonly causes optic neuritis, often affecting both eyes and often with swelling of the optic disc, as well as spinal cord inflammation and, particularly in children, a widespread brain inflammation.
  • It is more common in children than MS-like presentations are, but occurs at any age.
  • Many people have a single episode and no further attacks, which is a different prognosis from MS, and attacks typically recover better than NMOSD attacks.
  • Treatment differs: steroids, often prolonged, and immunoglobulin or other immune treatments rather than standard MS drugs.

Why it matters

Because the outlook and treatment differ substantially, antibody testing matters before someone is committed to lifelong MS therapy.

What's still uncertain

  • How best to prevent relapses in MOGAD is still being established.

Read more

Next: B12 and other treatable causes

Part 3 of 5

Reversible if caught

Review of many studies

What happens

Some mimics are corrected rather than managed.

What the research shows

  • Vitamin B12 deficiency damages the back and side columns of the spinal cord, causing numbness, tingling, unsteadiness and weakness, with white matter changes on MRI. It is treatable with replacement, and permanent if left long enough.
  • Causes include pernicious anaemia, low intake on a vegan diet without supplementation, long-term metformin or acid-suppressing medication, and gastric surgery.
  • Copper deficiency produces a near-identical picture, most often after gastric surgery or from excess zinc.
  • Thyroid disease, Lyme disease, syphilis and HIV can all produce neurological symptoms and are tested for.
  • Spinal cord compression from a disc or from narrowing in the neck produces symptoms that look like a spinal MS lesion and needs completely different treatment.

Why it matters

These are the reason blood tests and a spinal MRI are part of the workup rather than optional extras.

What's still uncertain

  • Nerve damage from prolonged B12 deficiency may only partly recover.

Read more

Next: Inflammatory and vascular

Part 4 of 5

The harder ones

Review of many studies

What happens

Conditions that affect the brain through other inflammatory or vascular routes.

What the research shows

  • Neurosarcoidosis, central nervous system vasculitis, lupus and Sjogren's syndrome can all cause relapsing neurological symptoms with abnormal scans.
  • Clues include involvement outside the nervous system: rash, dry eyes and mouth, joint pain, lung changes, kidney problems, or raised inflammatory markers.
  • Small vessel disease from high blood pressure, diabetes and age produces white matter spots that are extremely common after fifty and are routinely mistaken for demyelination.
  • Migraine with aura also produces white matter spots, and episodic neurological symptoms, which is a frequent source of confusion in young women.
  • CADASIL and other inherited conditions cause white matter changes with migraine, strokes and family history.

Why it matters

The location and shape of lesions distinguish these more reliably than their presence: MS lesions have a characteristic pattern, and a radiologist's phrase about non-specific white matter change is not a diagnosis.

What's still uncertain

  • Distinguishing these can require biopsy in a minority of cases.

Read more

Next: Asking the question

Part 5 of 5

When a second look is reasonable

Review of many studies

What happens

Circumstances in which revisiting the diagnosis is sensible rather than anxious.

What the research shows

  • The diagnosis rested on an MRI report alone without a typical clinical episode.
  • Spinal fluid was normal and the MRI is atypical.
  • Symptoms have been steadily progressive from the start in a young person, with no relapses.
  • Treatment has had no effect on a pattern of symptoms over years, or symptoms worsened after starting an MS drug.
  • Features outside the nervous system suggest a systemic disease, or there are prominent headaches, fever or weight loss.
  • Asking what the diagnosis rests on, and whether aquaporin-4 and MOG antibodies were tested, is a reasonable question and a normal part of specialist practice.

Why it matters

A confident, well-documented MS diagnosis does not need re-litigating. An uncertain one is worth a second opinion rather than years of treatment.

What's still uncertain

  • Re-evaluating a longstanding diagnosis is difficult once treatment has altered the course.

Read more

More plain-language reading

See something wrong or unclear on this page? Suggest a correction. OwieClear is for education only and isn't medical advice.